TCHBF

Healthcare Medical Instruments & Supplies

Tecan Group AG

$271.00

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

3.34B

Avg Volume

EPS

-$11.54

52W High

$271.00

52W Low

$155.25

Div. Yield

1.1%

Valuation

P/B Ratio

2.49

P/S Ratio

3.84

EV/EBITDA

45.50

EV/Revenue

3.82

Margins

Gross Margin 34.1%

Operating Margin 4.2%

Net Margin (13.4%)

EBITDA Margin 8.4%

Growth & Returns

Revenue Growth (YoY)

(2.7%)

Earnings Growth (YoY)

(29.8%)

Earnings Growth (QoQ)

(31.5%)

Return on Equity

(9.7%)

Return on Assets

1.4%

Liquidity & Leverage

Current Ratio

2.32

Quick Ratio

1.50

Debt / Equity

0.19

Total Cash

224.48M

Total Debt

214.32M

About

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.